Dawa Hillary Sherpa (52 años, de Okhaldhunga, Nepal), guía sherpa experimentado, fue dejado atrás el 29 de mayo de 2026 (último día de la temporada) durante el descenso del Everest, cerca de la zona de la muerte.
Dawa guiaba a un cliente polaco con Himalayan Traverse Adventure (agencia nepalí). El cliente —que escalaba sin oxígeno suplementario— sufrió congelaciones graves cerca del Collado Sur (Campo 4, 7.950m), por lo que dieron la vuelta.
En el descenso por la Cara de Lhotse (cerca del Campo 3 / Yellow Band, 7.500-7.600 m), Dawa se detuvo a descansar con mochila pesada y les dijo al cliente y a otro sherpa que siguieran. Se separaron.
El cliente y otro sherpa llegaron al Campo 2 (6.400 m), de donde fueron evacuados en helicóptero. Dawa no apareció.
La temporada en el Everest cerraba ese mismo día. Los Icefall Doctors retiraban las escaleras de la Cascada de Hielo del Khumbu poco después (zona 5.500-6.000 m).
Su empresa tardó días en reportarlo y no activó una búsqueda inmediata.
El miércoles 3 de junio subió un helicóptero (de 8K Expeditions, a petición de la familia), pero no lo vio a pesar de buscar desde la Cascada de Hielo hasta Campo 3.
Críticas duras por negligencia y falta de apoyo.
Final milagroso (hoy, 4 de junio): Dawa sobrevivió 6-7 días solo en la montaña (sin oxígeno, sin comida, solo, sin ayuda).
Bajó arrastrándose más de 2.000 m por la vertiginosa Cara de Lhotse, Western Cwm y la peligrosa Cascada de Hielo del Khumbu, arrastrándose hacia el Campo Base . Un equipo de limpieza lo encontró cerca del Crampon Point, consciente pero con graves congelaciones. Dawa hablaba lento y estaba débil. Le dieron una sopa caliente. Fue evacuado en helicóptero a Kathmandu, donde está en el hospital recuperándose.
Su familia ya preparaba los funerales.
Pero como dice la canción de Cheo Gallego:
"Nadie sabe si luego de la muerte podemos vernos,
nunca;
Que si el infierno que resguardas tú
Lo guardas, pero en tu yo interno
NUNCA."
📷Mingmar Sherpa/Capitán Bibek Khadka
World's First Telerobotic - Uretric Implantation performed at AINU Hospital-Hyderabad from Wuhan, China. The future of healthcare is no longer limited by distance. It is connected by precision. @drsmguro
Long segment PUJ obstruction is a rare entity you may encounter whilst planning for Pyeloplasty. Pelvic flap is a great option in tackling these situations. This is a short video of a flap pyeloplasty for one such case .
New urodynamics technology: Wireless, Tubeless UDS with @bright_uro supported by years of research from @CleClinicUro. Glean system now FDA approved coming to Europe - stay tuned. #EAU2026
🔬 Innovation spotlight: Early apical release in HoLEP
This technical modification reduced our operative time by 23 minutes average while improving continence outcomes.
Sometimes the biggest advances come from small technical details and simple ideas.
Key: Carefully release apex at the beggining of the operation, protect the external urinary sphincter → cleaner plane, less trauma.
#HoLEP #TechnicalTip #UrologyInnovation #ProstateSurgery
ESMO 2026 reshapes advanced prostate cancer care
From de novo mCSPC to molecularly defined mCRPC, treatment is now earlier, intensified, and genotype-driven.
🧬 mCSPC
🟢 Low volume
→ ADT + ARPI is standard
🟣 High volume
→ Fit patients: ADT + docetaxel + ARPI (triplet)
→ Unfit for docetaxel: ADT + ARPI
⚠️ ADT alone is obsolete except in frail patients
❌ Zoledronic acid / denosumab NOT recommended in mCSPC
🧠 Relapsed mCSPC
• Low volume: ADT + ARPI
• High volume: ADT + ARPI ± docetaxel (selected)
🧬 mCRPC without known mutations
• Prior ADT only: ARPI or docetaxel
• Post-ARPI: docetaxel or ¹⁷⁷Lu-PSMA-617
• Post-docetaxel + ARPI: ¹⁷⁷Lu-PSMA-617 or cabazitaxel
🧬 mCRPC with genetic alterations
• BRCA: PARP inhibitor ± ARPI > chemotherapy
• PALB2 / CDK12: selective PARPi use
• dMMR: PD-1 / PD-L1 inhibitor early
• Aggressive variant / NEPC: platinum-based chemotherapy
🦴 Bone health
✅ All mCRPC with bone mets must receive BPA
❌ Not for mCSPC
💡 Takeaway
Earlier intensification. Mandatory genomics. Radioligand therapy mainstream.
🔖 Save this for daily OPD decisions
📖 Full paper in comment ⬇️
#OncoTwitter #MedTwitter #ProstateCancer #GUOncology
@OncoAlert@myesmo@esmo_open@asco@Annals_Oncology
Dear friends, I have something important to tell you.
In December 2024, 'researchers' from multiple Indian Government Homeopathy institutions along with 'researchers' from Israeli Homeopathy institutes, published a randomized controlled trial that concluded that use of Homeopathic formulations in children during first 24 months of life reduced infections and antibiotics use compared to 'standard of care.' This was published in the prestigious European Journal of Pediatrics.
The study was viral. It was all over the media and news here in South India and also in some National media and was Whatsapp 'proof' of Homeopathy being better than modern medicine in infants. The study was used to promote anti-vaccine sentiments and Homeopathy products in South India. Homeopaths hailed the study as 'path breaking' - also because the Ayush Ministry and Government Homeopathy practitioners were study authors involved in it.
I read the study. I am trained in advanced statistics and research writing.
The study was utter nonsense. And fraud. It looked like the authors did not even actually perform the study. I really doubted whether any patients were involved at all.
I wrote a letter to the editor of the journal, asking him to kindly review the paper and investigate 'scientific integrity' and ethics.
And after nearly 10 months of investigations by the Journal, Publisher and Research Integrity Team, we were proven correct.
The paper was fraud and now it has been RETRACTED. @RetractionWatch
The lesson here is that, if people really did understand what Homeopathy is and what its practitioners are, it is easy to find that it is clearly fraud. There is nothing in Homeopathy that works. It is unscientific utter nonsense. Every positive study on Homeopathy is mostly published in 'Homeopathy' journals. Sometimes, it infiltrates a real, valid journal (like in this case) and then it gets retracted because the scientific community is always alert.
There are many such instances: See - https://t.co/JHC3anPss3 and https://t.co/iDRNha2Yw5 and https://t.co/84S02zuxv3
The worst part here is that all these Homeopathy practitioners who are authors of the study are working in Indian Govt. public health sector - meaning, their salary is paid from public funds and citizens taxes. These wastrels are eating away our hard earned money and using it to fund fraud. Who will stop these criminals?
Even worse, the fraud, now retracted study was published as 'open access' in the European Journal of Pediatrics - which means, the authors paid £3090.00 GBP or $4990 USD, or €3990 EUR equivalent in INR to publish fraud. Where did they get this money from? Yes. Indian public tax money.
Homeopathy needs to be booted out of this country. Parents, do not send your children to study Homeopathy even though India offers a 5 year course and gives them a "Dr." title at the end of it. They are not doctors. They are legitimized frauds and legalized quacks, as you can see from this retraction.
"Homeopathy is a lively relic of the prescientific era. Not healthcare."
@arifhussaintm
Link:
https://t.co/0CxLrVMHDj
Last month,I was on a tour to Rajasthan. Was wondering what ails Indian Tourist Industry.
Here r some of my observations:
India has everything, except the basics.
Ancient temples, centuries old-architectural marvels, wild mountains, a civilisation that breathes through food, festivals, stone and song. Yet travellers remember something else.
🫱 Filthy restrooms.
🫱 Journeys that collapse at the last mile.
🫱 Fleecing masked as hospitality,
or a cringe-worthy servility to white skin.
Both are ugly. Both are shameful.
🫱 Signage that vanishes, accessibility that never arrives.
🫱 Streets that turn unsafe after dusk.
🫱 Policing that watches, but does not care.
“Incredible India” shines on billboards, but fades the moment one steps outside the frame.
Tourism is not a slogan. It is cleanliness, safety especially for women,dignity, comfort, and ease.
Until we fix the experience,
not just market the postcard,
India will be visited, but it will never be recommended.